Vasa Therapeutics’ $6 Million Seed Funding Round

Pillsbury Winthrop Shaw Pittman LLP advised Vasa Therapeutics, Inc. on the round.Vasa Therapeutics, Inc., a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, announced the closing…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now